Oncology Cheat Sheet 2026: One-Page Review of Must-Know Facts

Which Oncology Exam This Cheat Sheet Covers

This page is a compressed review of the physician subspecialty certification in Oncology offered through the American Osteopathic Board of Internal Medicine (AOBIM), with certification approval through the American Osteopathic Association (AOA). It is not a summary of the ABIM Medical Oncology examination, and it is not a combined hematology-oncology exam. The two pathways differ in certifying body, blueprint, scoring scale, and renewal mechanics, so facts from one should never be assumed for the other. If you want the broader context, the Oncology Certification overview explains how the credential fits into osteopathic internal medicine.

Use this sheet as a final-pass reference after you have worked through a full syllabus. For a structured first pass, start with the Oncology Study Guide 2026: How to Pass on Your First Attempt, then return here to check recall of the facts that most often decide borderline scores.

Format, Scoring, and Fee Facts

Memorize these mechanics cold. They are the facts candidates most often get wrong when they rely on forum memory or on information about a different oncology credential.

Fee mechanics worth remembering

• The base exam fee is $800. Registering late adds $240, so the combined total is $1,040.
• The score audit is optional and costs $200. The request window is one month from the release of results, so decide quickly if you intend to use it.
• The numbers above are exam-related fees only. For a fuller picture including preparation costs and renewal, see Oncology Certification Cost 2026: Complete Pricing Breakdown.

The 17-Area Blueprint at a Glance

The AOBIM blueprint assigns each content area an official percentage range. Study to the ranges as published rather than to midpoints or to a different board's outline. Ranges overlap, so the practical takeaway is relative emphasis: two areas dominate, several sit in the middle, and a long tail of small areas still produce questions on every exam.

A deeper walk through each area, including how topics cluster, is in Oncology Exam Domains 2026: Complete Guide to All 17 Content Areas.

High-Yield Content in the Heaviest Areas

Mid-Weight Areas That Decide Close Scores

The areas in the 4-10% band are where many candidates pick up or lose the margin that separates a pass from a near miss. Each is large enough to matter and broad enough to punish shallow review.

Gastrointestinal tumors (6-10%)

• Colorectal cancer: staging-driven adjuvant decisions, the role of mismatch-repair status, and hereditary syndromes.
• Gastric and esophageal cancers: histology, risk factors, and multimodality treatment concepts.
• Biomarker-driven therapy as a recurring theme across GI tumors.

Chemotherapy toxicity (6-10%)

• Pair each major drug class with its signature toxicity: cardiotoxicity, pulmonary toxicity, neuropathy, nephrotoxicity, and myelosuppression patterns.
• Know monitoring strategies and dose-modification logic, not only the names of toxicities.
• Expect scenario questions that ask which agent most likely caused a described adverse effect.

Breast tumors (5-9%)

• Receptor status (hormone receptor and HER2) as the organizing principle for treatment selection.
• Adjuvant endocrine therapy considerations and their characteristic adverse effects.
• Hereditary risk and genetic counseling triggers.

Supportive care, palliative care, and ethics (5-9%)

• Symptom management: pain, nausea and vomiting, cachexia, dyspnea, and fatigue.
• Goals-of-care communication, advance care planning, and hospice eligibility concepts.
• Ethical principles in oncology practice, including informed consent, capacity, and surrogate decision making.

Thoracic tumors (4-8%) and paraneoplastic syndromes (4-8%)

• Thoracic: small cell versus non-small cell distinctions, the importance of molecular testing in non-small cell disease, and staging-based treatment pathways.
• Paraneoplastic: match syndrome to associated tumor (for example, endocrine, neurologic, and hematologic manifestations) and know the first-line management of the underlying problem such as hypercalcemia or SIADH.

Small Areas You Should Not Skip

Eight of the 17 areas carry upper bounds of 6% or less. Individually they are small, but together they represent a meaningful share of the exam, and the questions tend to be more fact-based than reasoning-based, which makes them cost-effective to review.

• Gynecologic tumors (3-7%): ovarian, endometrial, and cervical cancer; hereditary links to ovarian and endometrial risk; the role of screening and vaccination in cervical disease.
• Pharmacology/cancer biology/cancer genetics (2-6%): mechanisms of drug classes, tumor suppressors and oncogenes, and hereditary cancer syndromes.
• Pancreatic/liver cancer (2-6%): resectability concepts, risk factors for hepatocellular carcinoma, and surveillance in at-risk populations.
• Prevention/screening (2-6%): guideline-based screening concepts across common cancers and chemoprevention principles.
• Skin cancer (1-5%), head and neck cancer (1-5%), and bone/soft tissue/sarcoma (1-5%): histology, risk factors, and the distinguishing features of each entity; know melanoma staging concepts and the major sarcoma categories at a recognition level.
• Opportunistic infection (1-4%): infection risk in neutropenia and immunosuppression, prophylaxis principles, and febrile neutropenia management.
• Cancer trials (1-3%): trial design vocabulary, endpoints, and interpreting results at a conceptual level.

Eligibility Checklist

Confirm every item before you start an application, because missing documentation is a common source of delay. The complete walkthrough is in Oncology Requirements 2026: Eligibility, Prerequisites & How to Qualify.

1. AOA board certification in internal medicine.
2. Two years of an ACGME-accredited or AOA-recognized Oncology or Hematology/Oncology fellowship.
3. An active medical license.
4. Ethical standing.
5. A completed application with program-director verification.

A qualifying three-year combined or separate hematology/oncology training route can support applications for the separate Hematology and Oncology examinations. If your training path is unusual, verify with AOBIM how your fellowship counts before you register. Scheduling logistics and deadlines are covered in Oncology Exam Dates 2026: Testing Windows, Deadlines & Scheduling.

The Ten-Year Term and OCC

Initial certification has a ten-year term, and it stays valid only while you meet Osteopathic Continuous Certification (OCC) requirements. This cheat sheet's exam content describes initial certification only; renewal works differently.

• You may begin the OCC subspecialty examination two years before your certificate expires.
• A successful early renewal extends from the existing certificate's expiration date, so testing early does not cost you remaining time.
• Keep Oncology OCC separate in your mind from the primary internal-medicine longitudinal assessment. They are distinct obligations with different requirements.

For the career-value side of maintaining the credential, read Is the Oncology Certification Worth It? Complete ROI Analysis 2026.

A Domain-Ordered Review Schedule

If you have limited time, sequence your review by blueprint weight and by how much each area benefits from early exposure. This is the one structured plan in this article; adapt the week count to your own timeline.

Practice with original questions and explanations mapped to the AOBIM Oncology outline, and use the Oncology Exam Prep practice tests to pressure-test recall under timed conditions. Because the real exam runs seven hours across 300 questions, build stamina with long mixed-topic sets in the final weeks. If you are unsure how much preparation you need, How Hard Is the Oncology Exam? Complete Difficulty Guide 2026 helps calibrate expectations, and the main practice site lets you track weak domains over time.

Frequently Asked Questions